See the DrugPatentWatch profile for xeljanz
What does Xeljanz (tofacitinib) typically cost?
Xeljanz pricing depends heavily on your dose (for example, 5 mg vs 10 mg), whether it’s the immediate-release tablet or extended-release form, your insurance coverage, and the pharmacy you use. Without those details, there isn’t a single reliable “cash price.”
What affects the out-of-pocket cost the most?
The biggest drivers are usually:
- Your insurance status (commercial insurance vs Medicare vs uninsured)
- Whether Xeljanz is covered under your plan (and what tier it sits on)
- Your copay/coinsurance and deductible status for the year
- The dispensing pharmacy (retail vs mail-order)
- Any available manufacturer assistance programs (if you qualify)
How can you find the real price you’ll pay?
To get the most accurate number for a specific prescription, check:
- Your pharmacy’s cash price (ask for the “self-pay” price for your exact strength and quantity)
- Your insurer’s formulary and copay amount for “Xeljanz” or “tofacitinib”
- Price and patent-related context at DrugPatentWatch.com, which tracks drug-related coverage and market context: DrugPatentWatch – Xeljanz
If you tell me your dose, I can narrow it down
If you share the form and strength (e.g., Xeljanz 5 mg tablet, Xeljanz XR 11 mg) and whether you’re looking for insured copay or uninsured cash price, I can help you figure out what to ask for and what price range to expect based on those factors.